Seòmar agus comataidhean

I refer the member to the answer to question S6W-03286 on‎ 1 October 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers
‎

NHS bodies, Local Authorities and other public sector bodies that use Scottish Government’s national collaborative framework for the Supply of Natural Gas will see no increase in price this financial year to their wholesale cost of gas. The cost of wholesale gas was fixed in April 2021 and will remain unchanged this financial year. Information is not held centrally for those public bodies that do not use the national collaborative framework.

In general terms, in the event that any Land and Buildings Transaction Tax, including the Additional Dwelling Supplement, is due in relation to a transaction it could not be reclaimed.

The Scottish Government does not hold this information.

Revenue Scotland, in its role as Scotland’s fully devolved tax collection and management authority, regularly publishes data on its website regarding the number of transactions subject to Land and Buildings Transaction Tax (LBTT), including the Additional Dwelling Supplement. The LBTT tax return does not however allow for capture of the information requested.

As of August 23rd there are 8,220 records flagged receiving 2 doses of mixed COVID-19 vaccine products in the National Clinical Data Store (NCDS).

There are 7,697,632 total records ( first and second doses ) in the NCDS relating to COVID-19 vaccinations therefore this number is 0.11% of records flagged.

The circumstances for these are not recorded.

Data completeness and accuracy checks have not yet been carried out on each of these records, therefore some of these records may be duplicates, or in fact relate to more than a single individual.

The Scottish Government is grateful to everyone who has volunteered for COVID-19 vaccine trials in Scotland. The clinical trials participants have made an important contribution in tackling the coronavirus pandemic.

The digital application to record the COVID-19 vaccine will be available from 30th September. Clinical trial participants who have received a licenced product and are un-blinded will be able to access the application.

Other clinical trial participants will not have access to the application at this time. However, other measures are in place to provide proof of vaccination. This includes a letter of support and subsequently participants will receive a hard copy Record of Vaccination which contains security features and 1-D barcode.

This Record of Vaccination can be used across the UK. In due course, this will be replaced by a QR Record of Vaccination with a QR code.

The Scottish Government are committed to ensuring that these participants are not disadvantaged. Work is ongoing to ensure that vaccine status is correctly presented on the coronavirus vaccine database.

All those individuals who have participated in coronavirus vaccine clinical trials in Scotland, should have already received a letter from their Chief Investigator confirming their involvement. The letter allows them to attend events or access services throughout the UK in the same way as those who are fully vaccinated.

You may find more information on clinical trials on NHS inform: Coronavirus (COVID-19) vaccination status for clinical trial participants | The coronavirus (COVID-19) vaccine (nhsinform.scot)

There is no data held on reasons for missed or non attendance for COVID-19 vaccine appointments.

In the statistical report for 16th of June 2021, Public health Scotland published a one-off analysis of "did not attend" (DNA ) appointments for the time period between 1 February 2021 and 6 June 2021. In this they found that 18.2% of first dose appointments and 3.9% of second dose appointments had resulted in either a missed appointment or a cancellation. The full report is available here : COVID-19 Statistical Report - 16 June 2021 - COVID-19 statistical report - Publications - Public Health Scotland

Information on the location of vaccinations, cross referenced with the recipients health board, is not held centrally.

There is evidence that achieving the stroke bundle reduces mortality and increases the chance of patients returning to their usual place of residence after stroke.

There are a number of other factors in achieving an acceptable level of care for people with stroke. However, the stroke bundle is a simple metric which has been shown to be associated with improved outcomes. The Scottish Stroke Improvement Programme Team will continue to support NHS Boards to achieve the Stroke Bundle as well as supporting improvements across the stroke pathway.

Our Detect Cancer Early (DCE) Programme is aimed at increasing early diagnosis rates of Scotland’s most common cancers while reducing health inequalities. Following an options appraisal exercise, melanoma was selected as the next tumour type for inclusion in the DCE Programme in 2016.

DCE’s website (getcheckedearly.org) and digital channels help to increase awareness of symptoms of a number of tumour groups, including melanoma, on an ongoing basis. The Programme also works closely with third sector to share patient experience stories, to prompt others to take action.

DCE launched a new overarching campaign – Survivors - in September 2018 to reduce fear of cancer and empower people to act early, if they noticed any possible signs of cancer. The NHS Recovery Plan, published 25 August 2021, commits a further £20 million investment to the DCE Programme which will include additional public awareness campaigns.